Change in stage distribution of breast cancer since the implementation of nation-wide screening; investigation in the Netherlands over the period 1989-1995;Veranderde stadiumverdeling van borstkanker sinds de invoering van de landelijke screening; onderzoek over de periode 1989-1995

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 23, 2000, Pages 1119-1123

  Van Dijck, J A A M ^a   Hendriks, J H C L ^a   Holland, R ^a   Schouten, L J ^a   Verbeek, A L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034600520     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Day NE, Williams DRR, Kwah KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.
2. Akker-van Marle ME van den, Koning HJ de, Boer R, Maas PJ van der. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands; comparison with the United Kingdom. J Med Screen 1999;6:30-4.
3. Visser O, Coebergh JWW, Schouten LJ, Dijck JAAM van, editors. Incidence of cancer in the Netherlands 1995; seventh report of the Netherlands Cancer Registry. Utrecht: Vereniging Integrale Kankercentra; 1998.
4. Schouten LJ, Höppener P, Brandt PA van den, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, the Netherlands. Int J Epidemiol 1993;22:369-76.
5. Schouten LJ, Straatman H, Kiemeney LALM, Gimbrère CHF, Verbeek ALM. The capture-recapture method for estimation of cancer registry completeness: a useful tool? Int J Epidemiol 1994; 23:1111-6.
6. Hermanek P, Sobin LH, editors. International Union Against Cancer (UICC): TNM classification of malignant tumours. 4th ed. Berlijn: Springer; 1987.
7. Landelijk Evaluatieteam voor bevolkingsonderzoek naar Borstkanker. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland (VI). Rotterdam: Instituut Maalschappelijke Gezondheidszorg, Erasmus Universiteit Rotterdam; 1997.
8. Prior P, Woodman CBJ, Wilson S, Threlfall AG. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screen 1996;3:119-22.
9. Nab HW, Beek MWPM van, Crommelin MA, Heijden LH van der, Kluck HM, Coebergh JWW. Toegenomen incidentie van borstkanker in Zuidoost-Nederland tussen 1960 en 1989. Ned Tijdschr Geneeskd 1992;136:1765-70.
10. Boer R, Warmerdam P, Koning H de, Oortmarssen G van. Extra incidence caused by mammographic screening [letter]. Lancet 1994; 343:979.
11. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1984;1:1222-4.
12. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F. Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen project, 1975-82 [letter]. Lancet 1985;i: 865-6.
13. Schouten LJ, Rijke JM de, Schlangen JT, Verheek ALM. Evaluation of the effect of breast cancer screening hy record linkage with the cancer registry, the Netherlands. J Med Screen 1998;5:37-41.
14. McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast cancer screening programme on stage at diagnosis. J Med Screen 1998;5:42-8.
15. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
16. Velde CJH van de, Rutgers EJT. Positieve ontwikkelingen voor patiënten met mammacarcinoom als gevolg van de schildwachtklier-procedure. Ned Tijdschr Geneeskd 1998;142:2240-2.
17. Ruers TJM, Roumen RMH. Schildwachtklierbiopsie bij patiënten met mammacarcinoom: aanbevelingen voor de introductie van deze techniek. Ned Tijdschr Geneeskd 1998;142:2237-40.
18. Maas PJ van der, Koning HJ de, Ineveld BM van, Oortmarssen GJ, Habbema JD, Lubbe KT, et al. The cost-effectiveness of breast cancer screening, Int J Cancer 1989;43:1055-60.
19. Coebergh JWW, Heijden LH van der, Janssen-Heijnen MLG. editors. Cancer incidence and survival in the southeast of the Netherlands, 1955-1994. Eindhoven: Integraal Kankercentrum Zuid; 1995.
20. Jatoi I, Baum M. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery 1995:118:118-20.
21. Verbeck ALM. Population screening in Nijmegen, an evaluation of the period 1975-1982. Nijmegen: Katholieke Universiteit Nijmegen; 1985. p. 126-8.